Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q2 2015 (← Previous) (Next →)
Filing Date: Aug 14, 2015
Total Value: $1.22B (99.6% shares, 0.4% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 13,623,620 | $98.23M | 8.1% | $5.07 | — | COM | 04269X105 |
| FOLD | AMICUS THERAPEUTICS INC | 6,297,523 | $89.11M | 7.3% | $3.90 | +208.4% | COM | 03152W109 |
| — | VALEANT PHARMACEUTICALS INTL | 384,506 | $85.42M | 7.0% | $159.08 | — | COM | 91911K102 |
| — | CLOVIS ONCOLOGY INC | 759,479 | $66.74M | 5.5% | $44.43 | — | COM | 189464100 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 967,359 | $57.17M | 4.7% | $61.93 | — | ADR | 881624209 |
| — | ALLERGAN PLC | 136,818 | $41.52M | 3.4% | $303.46 | — | SHS | G0177J108 |
| — | KYTHERA BIOPHARMACEUTICALS I | 482,556 | $36.34M | 3.0% | $63.58 | — | COM | 501570105 |
| HCA | HCA HOLDINGS INC | 390,000 | $35.38M | 2.9% | $74.47 | 0.0% | COM | 40412C101 |
| ABBV | ABBVIE INC | 510,010 | $34.27M | 2.8% | $42.33 | 0.0% | COM | 00287Y109 |
| — | AETNA INC NEW | 264,075 | $33.66M | 2.8% | $110.66 | — | COM | 00817Y108 |
| — | CHIMERIX INC | 699,425 | $32.31M | 2.6% | $22.91 | — | COM | 16934W106 |
| — | CIGNA CORPORATION | 198,700 | $32.19M | 2.6% | $162.00 | — | COM | 125509109 |
| BIIB | BIOGEN INC | 79,118 | $31.96M | 2.6% | $362.98 | +10.6% | COM | 09062X103 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 207,744 | $28.41M | 2.3% | $123.92 | 0.0% | COM | 09061G101 |
| — | RECEPTOS INC | 144,205 | $27.41M | 2.2% | $36.95 | — | COM | 756207106 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 150,866 | $26.56M | 2.2% | $174.31 | +3.0% | SHS USD | G50871105 |
| — | SEATTLE GENETICS INC | 529,199 | $25.61M | 2.1% | $32.96 | — | COM | 812578102 |
| UHS | UNIVERSAL HLTH SVCS INC | 175,965 | $25M | 2.0% | $119.82 | 0.0% | CL B | 913903100 |
| — | HEALTH NET INC | 388,128 | $24.89M | 2.0% | $51.58 | — | COM | 42222G108 |
| — | ALERE INC | 461,170 | $24.33M | 2.0% | $48.90 | — | COM | 01449J105 |
| — | NANOSTRING TECHNOLOGIES INC | 1,459,742 | $22.51M | 1.8% | $13.36 | — | COM | 63009R109 |
| — | SAGE THERAPEUTICS INC | 290,350 | $21.2M | 1.7% | $73.00 | — | COM | 78667J108 |
| INSM | INSMED INC | 867,346 | $21.18M | 1.7% | $15.76 | +44.0% | COM PAR $.01 | 457669307 |
| — | ATARA BIOTHERAPEUTICS INC | 372,642 | $19.66M | 1.6% | $34.25 | — | COM | 046513107 |
| — | INTRA CELLULAR THERAPIES INC | 610,171 | $19.5M | 1.6% | $18.07 | — | COM | 46116X101 |
| — | GW PHARMACEUTICALS PLC | 146,027 | $17.94M | 1.5% | $96.98 | — | ADS | 36197T103 |
| INCY | INCYTE CORP | 164,995 | $17.19M | 1.4% | $103.51 | 0.0% | COM | 45337C102 |
| — | MODEL N INC | 1,443,278 | $17.19M | 1.4% | $10.53 | — | COM | 607525102 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 1,212,892 | $16.8M | 1.4% | $17.17 | — | ORD SHS | G6855A103 |
| — | CASTLIGHT HEALTH INC | 1,984,631 | $16.16M | 1.3% | $12.24 | — | CL B | 14862Q100 |
| — | ZS PHARMA INC | 302,988 | $15.87M | 1.3% | $39.46 | — | COM | 98979G105 |
| — | ONCOTHYREON INC | 4,164,878 | $15.58M | 1.3% | $3.74 | — | COM | 682324108 |
| — | CIVITAS SOLUTIONS INC | 657,693 | $14.03M | 1.1% | $16.04 | — | COM | 17887R102 |
| FATE | FATE THERAPEUTICS INC | 2,007,446 | $12.99M | 1.1% | $5.98 | 0.0% | COM | 31189P102 |
| DVA | DAVITA HEALTHCARE PARTNERS I | 140,191 | $11.14M | 0.9% | $76.74 | +7.0% | COM | 23918K108 |
| — | BLUEPRINT MEDICINES CORP | 378,235 | $9.671M | 0.8% | $25.57 | — | COM | 09627Y109 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 537,282 | $8.725M | 0.7% | $27.64 | — | COM | 05337G107 |
| PRQR | PROQR THRAPEUTICS N V | 516,690 | $8.613M | 0.7% | $16.02 | +17.6% | SHS EURO | N71542109 |
| — | GENOCEA BIOSCIENCES INC | 623,519 | $8.561M | 0.7% | $11.86 | — | COM | 372427104 |
| LAB | FLUIDIGM CORP DEL | 348,237 | $8.427M | 0.7% | $30.66 | +2.9% | COM | 34385P108 |
| CERS | CERUS CORP | 1,603,427 | $8.322M | 0.7% | $5.12 | -7.5% | COM | 157085101 |
| — | TRIVASCULAR TECHNOLOGIES INC | 1,464,563 | $7.835M | 0.6% | $14.40 | — | COM | 89685A102 |
| — | PORTOLA PHARMACEUTICALS INC | 152,700 | $6.955M | 0.6% | $45.55 | — | COM | 737010108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 67,425 | $6.904M | 0.6% | $55.55 | +39.8% | COM | 90400D108 |
| — | BELLICUM PHARMACEUTICALS INC | 238,121 | $5.065M | 0.4% | $20.06 | — | COM | 079481107 |
| — | ARRAY BIOPHARMA INC | 4,000,000 | $5.05M | 0.4% | $1.09 | — | NOTE 3.000% 6/0 | 04269XAA3 |
| — | CHEMOCENTRYX INC | 476,293 | $3.92M | 0.3% | $8.20 | — | COM | 16383L106 |
| — | ELEVEN BIOTHERAPEUTICS INC | 1,261,260 | $3.557M | 0.3% | $4.54 | — | COM | 286221106 |
| — | FLEXION THERAPEUTICS INC | 142,483 | $3.119M | 0.3% | $16.39 | — | COM | 33938J106 |
| — | AXOVANT SCIENCES LTD | 150,000 | $3.057M | 0.3% | $20.38 | — | COM | G0750W104 |
| — | INVITAE CORP | 181,224 | $2.563M | 0.2% | $13.94 | — | COM | 46185L103 |
| — | ADURO BIOTECH INC | 61,639 | $1.87M | 0.2% | $30.34 | — | COM | 00739L101 |
| IHF | ISHARES | 8,599 | $1.229M | 0.1% | $125.48 | — | US HLTHCR PR ETF | 464288828 |
| — | CELLDEX THERAPEUTICS INC NEW | 32,765 | $826K | 0.1% | $27.41 | — | COM | 15117B103 |
| — | MARKET VECTORS ETF TR | 6,500 | $460K | 0.0% | $45.08 | — | PHARMACEUTICAL | 57060U217 |